Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280251372646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Chijioke Okeke und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Prescription Drug Misuse Education and Research (PREMIER) Center, College of Pharmacy, University of Houston, Houston, TX, USA. Hauptthemen laut MEDLINE: Oxycodone, Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors, Opiate Overdose. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Concurrent use of oxycodone and strong cytochrome P450 2D6 (CYP2D6)-inhibiting selective serotonin reuptake inhibitors (SSRIs), specifically paroxetine and fluoxetine, is associated with the risk of opioid overdose.
Objective
This study assessed the association between the duration of concurrent oxycodone and CYP2D6-inhibiting SSRI use and overdose risk.
Methods
A retrospective cohort study conducted using the Merative MarketScan claims database from January 1, 2017, to December 31, 2019. Adults aged ≥18 years with private insurance who initiated both oxycodone and SSRIs were included. Patients were grouped as (1) oxycodone with other SSRIs (reference); (2) oxycodone with paroxetine or fluoxetine with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Prescription Drug Misuse Education and Research (PREMIER) Center, College of Pharmacy, University of Houston, Houston, TX, USA.
- Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA.
- Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, SC, USA.
ORCID-Profile: Chijioke Okeke, Ismaeel Yunusa
Zitieren
APA
Okeke, C., Olateju, O., Yunusa, I., Bhatt, P., & Thornton, J. D. (2025). Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251372646
Vancouver
Okeke C, Olateju O, Yunusa I, Bhatt P, Thornton JD. Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251372646
BibTeX
@article{Okeke2025,
author = {Okeke, Chijioke and Olateju, Olajumoke and Yunusa, Ismaeel and Bhatt, Prachet and Thornton, James Douglas},
title = {Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280251372646}
}
EUVIMED